• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • News

    Donors contribute $200M to boost child vaccine supply

    <i>Reuters says that donor nations agreed to provide $200 million to increase the supply of vital child vaccines in poor countries.</i> The Global Alliance for Vaccines and Immunizations (GAVI) revealed that donor nations promised to give $200 million to boost the supply of newly licensed vaccines for rotavirus and pneumococcus in developing countries. According to the World H&#8230;

    By Newswire Newsletter // 30 November 2006



    The Global Alliance for Vaccines and Immunizations (GAVI) revealed that donor nations promised to give $200 million to boost the supply of newly licensed vaccines for rotavirus and pneumococcus in developing countries. According to the World Health Organization, the viruses cause the largest preventable deaths among children in these countries. “Our goal now is to move quickly to save the lives of as many children as possible with the vaccines we have in hand,” GAVI Executive Secretary Julian Lob-Levyt said. The plan involves bringing two rotavirus vaccines manufactured by British drug giant GlaxoSmithKline and U.S. pharmaceutical firm Merck to 13 countries in Eastern European and South and Central America, and the pneumococcal vaccine Prevenar from Wyeth to 10 countries in Africa and South Asia over the next few years.

    Source: Rich nations donate $200 mln for child vaccines (Reuters)

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Newswire Newsletter

      Newswire Newsletter

    Search for articles

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      The UN's changing of the guard
    • 4
      Opinion: Urgent action is needed to close the mobile gender gap
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement